Citations 1
T100: Long term Follow-up of a Phase I Study Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma: A trial of the ECOG-ACRIN Research Group (E4412: Arms A-I)
Ambinder, Richard, Cohen, Jonathon B. , David, Kevin A. , Fenske, Timothy S. , Palmisiano, Neil , Svoboda, Jakub , Ansell, Stephen M. , Diefenbach, Catherine , Jegede, Opeyemi A. , Robertson, Michael J. , Advani, Ranjana H. , Barta, Stefan K , Morgan, David , Karmali, Reem , Kahl, Brad S.
HemaSphere | October 10, 2022 | Volume: 6 | Issue: No issue available | Pages: 46-47
